TrialJournal of diabetes2022

Lipid variability and risk of microvascular complications in Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial: A post hoc analysis.

Daniel Nyarko Hukportie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.